Omeprazole-cisapride combination for gastroparesis following radical gastrectomy for gastric cancer: An efficacy and safety analysis

Table 1 General patient information, n (%)/mean ± SD

Data	Control group (n = 92)	Research group (n = 106)	χ2/t	P value
Sex			0.604	0.437
Male	47 (51.09)	60 (56.60)
Female	45 (48.91)	46 (43.40)
Age (years)	55.86 ± 6.22	56.60 ± 8.42	0.694	0.488
Body mass index (kg/m2)	22.90 ± 2.29	22.79 ± 2.38	0.330	0.742
Mode of anesthesia			2.214	0.137
General anesthesia	38 (41.30)	55 (51.89)
Epidural anesthesia	54 (58.70)	51 (48.11)
Surgical technique			1.409	0.494
Gastroduodenostomy	36 (39.13)	42 (39.62)
Gastrojejunostomy	27 (29.35)	24 (22.64)
Roux-en-Y anastomosis	29 (31.52)	40 (37.74)
TNM staging			1.164	0.281
I-IIA	28 (30.43)	40 (37.74)
IIB-III	64 (69.57)	66 (62.26)
Surgical duration (hours)			1.901	0.168
< 4	37 (40.22)	53 (50.00)
≥ 4	55 (59.78)	53 (50.00)

TNM: Tumor-node-metastasis.